Screener
BioRestorative Therapies BRTX Q4 2024 Annual earnings
Reported March 27, 2025 · After market close
Revenue$43.3KMiss by $431.7K
EPS-$0.20Beat by $0.07
Revenue estimate$475.0K
EPS estimate-$0.27
Next report
Sep 22, 2026 (In 4 days)Revenue estimate$600.0K
EPS estimate-$2.00
Versus estimates
Revenue
Diluted EPS
FAQ
- When did BioRestorative Therapies report Q4 2024 earnings?
- BioRestorative Therapies (BRTX) reported Q4 2024 earnings on March 27, 2025 after market close.
- What were BioRestorative Therapies's Q4 2024 revenue and EPS?
- BioRestorative Therapies reported revenue of $43.3K and eps of $-0.20 for Q4 2024.
- Did BioRestorative Therapies beat estimates in Q4 2024?
- Revenue missed the consensus estimate of $475.0K by $431.7K. EPS beat the consensus estimate of $-0.27 by $0.07.
- Where can I find BioRestorative Therapies's Q4 2024 SEC filings?
- You can read the 8-K earnings release (0001021771-25-000066) and the 10-K periodic report (0001641172-25-001011) directly on SEC EDGAR. The filing index links above go to sec.gov.
